Potential future therapies for the management of cough: ACCP evidence-based clinical practice guidelines

Chest

Volumn 129, Issue 1 SUPPL., 2006, Pages 284S-286S

  Dicpinigaitis, Peter V ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

5 hydroxytryptamine; Antitussive; Cannabinoids; Capsaicin; Cough; Future therapies; Opioid; Potassium channel openers; Tachykinins; Vanilloid

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; ANTITUSSIVE AGENT; CODEINE; MORPHINE; OPIATE RECEPTOR AFFECTING AGENT; PIZOTIFEN; POTASSIUM CHANNEL STIMULATING AGENT; SEROTONIN AGONIST; TACHYKININ RECEPTOR ANTAGONIST;

CONSTIPATION; COUGHING; DRUG DEPENDENCE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HUMAN; NAUSEA; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT;

EID: 33144465033     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.1_suppl.284S     Document Type: Article

References (22)

1. Irwin RS, Curley FJ, French CL. Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outline of specific therapy. Am Rev Respir Dis 1990; 141:640-647
2. Pratter MR, Bartter T, Akers S, et al. An algorithmic approach to chronic cough. Ann Intern Med 1993; 119:977-983
3. McGarvey LP, Heaney LG, Lawson JT, et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998; 53:738-743
4. Midgren B, Hansson L, Karlsson J-A, et al. Capsaicin-induced cough in humans. Am Rev Respir Dis 1992; 146:347-351
5. Dicpinigaitis PV. Short- and long-term reproducibility of capsaicin cough challenge testing. Pulm Pharmacol Ther 2003; 16:61-65
6. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389:816-824
7. Mezey E, Toth ZE, Cortright DN, et al. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000; 97:3655-3660
8. Kotzer CJ, Hay DW, Dondio G, et al. The antitussive activity of delta-opioid receptor stimulation in guinea pigs. J Pharmacol Exp Ther 2000; 292:803-809
9. Boiser DC, McLeod RL, Tulshian DB, et al. Antitussive action of nociceptin in the cat. Eur J Pharmacol 2001; 430:107-111
10. 1 receptors. Br J Pharmacol 2001; 132:1175-1178
11. Jia Y, Wang X, Aponte SI, et al. Nociceptin/orphanin FQ inhibits capsaicin-induced guinea-pig airway contraction through an inward-rectifier potassium channel. Br J Pharmacol 2002; 135:764-770
12. Joos GF, Pauwels RA. Pro-inflammatory effects of substance P: new perspectives for the treatment of airway disease? Trends Pharmacol Sci 2000; 21:131-133
13. Advenier C, Lagente V, Boichot E. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough. Eur Respir J 1997; 10:1892-1906
14. Moreaux B, Nemmar A, Vincke G, et al. Role of substance P and tachykinin receptor antagonists in citric acid-induced cough in pigs. Eur J Pharmacol 2000; 408:305-312
15. Hay DW, Giardina GA, Griswold DE, et al. Nonpeptide tachykinin receptor antagonists: III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. J Pharmacol Exp Ther 2002; 300:314-323
16. El-Hashim AZ, Wyss D, Lewis C. Effect of a novel NK1 receptor selective antagonist (NKP608) on citric acid-induced cough and airway obstruction. Pulm Pharmacol Ther 2004; 17:11-18
17. Calignano A, Katona I, Desarnaud F, et al. Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature 2000; 408:96-101
18. Jia Y, McLeod RL, Wang X, et al. Anandamide induces cough in conscious guinea-pigs through VR1 receptors. Br J Pharmacol 2002; 137:831-836
19. Stone RA, Worsdell YM, Fuller RW, et al. Effects of 5-hydroxytryptamine and 5-hydroxytryptophan infusion on the human cough reflex. J Appl Physiol 1993; 74:396-401
20. O'Connell F. Central pathways for cough in man: unanswered questions. Pulm Pharmacol Ther 2002; 15:295-301
21. Fox AJ, Barnes PJ, Venkatesan P, et al. Activation of large conductance potassium channels inhibits the afferent and efferent function of airway sensory nerves in the guinea pig. J Clin Invest 1997; 99:513-519
22. Morita K, Kamei J. Involvement of ATP-sensitive K(+) channels in the antitussive effect of moguisteine. Eur J Pharmacol 2000; 395:161-164